Anavex Life Sciences Corp (AVXL)

[kevindenver]

I believe that question was answered. Focus on the dismal historical track record, and "the unknown" for your dark sarcasm. It keeps me entertained while I wait. I hear it just around the corner.

"As far as next steps go, we are expecting full comprehensive results of the entire AD 2b/3 trial, which will be presented via paper or otherwise. After of course, we look forward to speaking with the FDA, EMA, TGA, and other global regulators. We believe our biomarker suite is compelling for approval."

Ok. So with all endpoints of the P2b/3 AD trial met, then what is Missling waiting for then before speaking to FDA et. al?